Triglyceride clearance in subjects with heterozygous EXT1 or EXT2 Mutations

Triglyceride clearance in subjects with heterozygous EXT1 or EXT2 Mutations - TEAM

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33207

Enrollment

Registered

2009-11-23

Start date

2009-11-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertriglyceridemie Hereditary Multiple Exostosis Multiple Osteochondroma

Interventions

1. Fat loading test with subsequent blooddrawing 2. LPL-test using heparin

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: HME/MO or familyrelatedness to HME/MO

Exclusion criteria

Exclusion criteria: diabetes

Design outcomes

Primary

Measure	Time frame
Triglyceride clearance	—

Secondary

Measure	Time frame
LPL binding capacity Urine albumin and glycosaminoglycan profile	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)